Clinical trial
Selinexor in Combination With Chemotherapy to Treat Relapsed/Refractory Multiple Myeloma Patients
NCT04877275 is registered in ClinicalTrials.gov with Chunyan Sun, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Selinexor in Combination With Chemotherapy to Treat Relapsed/Refractory Multiple Myeloma Patients
- Lead sponsor
- Chunyan Sun, MD
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- May 21, 2021
- Completion date
- December 30, 2024
- Enrollment
- 50 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.